MammoMARK® and CorMARK®
Biopsy Site Identifier
Rapid expansion anchors the marker in place for unsurpassed placement accuracy.1
MammoMARK® and CorMARK® Biopsy Site Identifier
Expands Rapidly
The size increases by 300% within 60 seconds, reducing the likelihood of movement when releasing breast compression.1, 2
Provides Clear Ultrasound Visibility
The Increased surface area provides ease of ultrasound visibility at time of deployment.3
Enables Precise Placement
The MammoMARK® and CorMARK® markers help with accurate placement in the biopsy cavity.3
Absorbs Fluid Quickly
The MammoMARK® and CorMARK® markers assist in fluid management by quickly absorbing surrounding fluid.1
Two distinct shapes for better tracking of multiple biopsy sites
Shapes
- Bowtie
- U-Shape
“The most significant advantage we found with the MammoMARK® is the ability to consistently localize [it] using sonography.”
Krakos et al. Advantages of Using the New MammoMark Percutaneous Breast Biopsy marker – a Large Center Experience.
Frequently Asked Questions
What is the difference between the MammoMARK® and CorMARK® markers?
The applicators are the only difference between the two markers. The CorMARK® markers are the direct puncture applicators and the MammoMARK® markers encompasses all others.
What are the MammoMARK® and CorMARK® markers composed of?
The MammoMARK® and CorMARK® markers are composed of bovine collagen and titanium.
Do the MammoMARK® and CorMARK® markers contain any nickel?
No, the markers do not contain any nickel.
Related Products
HydroMARK™ Breast Biopsy Site Marker
The exclusive hydrogel technology provides unmatched long-term ultrasound visibility. 4
MammoSTAR® Biopsy Site Marker
The all-natural biopsy marker provides a non-metal marking alternative with a long-lasting beta glucan carrier for unique patient sensitivities.
1. MammoMARK® Device Test – PRC043442 Rev B, pgs. 2, 5-6: Collagen Expansion
2. Corsi, F., Sorrentino, L., Sartani, A., Bossi, D., Amadori, R., Nebuloni, M., Truffi, M., Bonzini, M., & Foschi, D. (2015). Localization of nonpalpable breast lesions with sonographically visible clip: Optimizing tailored resection and clear margins. The American Journal of Surgery, 209(6), 950-958
3. Corsi F, Sorrentino L, Bossi D, Sartani A, Foschi D. Preoperative localization and surgical margins in conservative breast surgery. Int J Surg Oncol. 2013;2013:793819. doi:10.1155/2013/793819
4. Sakamoto, N., Fukuma, E., Tsunoda, Y. et al. Evaluation of the dislocation and long-term sonographic detectability of a hydrogel based breast biopsy site marker. Breast Cancer 25, 575–582 (2018). https://doi.org/10.1007/s12282-018-0854-8
Products may not be approved or available in your region. Please check with your local Mammotome representative.